- CAR-T cells
- Stem cells
- Tumor-infiltrating lymphocytes
- TCR Therapy
- Cell Therapy
- Other
- CRISPR
- Multiple AAV serotypes
- Lentivirus
- Exosomes
Cell and Gene Development From R&D to Manufacturing to Market
Experience in every stage for complex cell and gene therapy studies and production
Contact us
Because of the inherent complexity of cell and gene development, Precision mobilizes a made-to-fit team of cross-functional, multidisciplinary experts who are study tested and help our clients solve clinical, regulatory, manufacturing and commercial challenges.
Driving cell and gene therapy innovations
Our experience developing multiple types of cellular therapies gives us the understanding to develop bespoke solutions for each therapeutic cell type including CAR-T cells, stem cells, and tumor-infiltrating lymphocytes. With leadership in gene therapy immunogenicity, a regulatory team that coordinates therapeutic and companion diagnostic strategy, and a focus on executing end-to-end clinical trials, Precision is well-positioned to guide successful gene therapy development.
We have built the largest advanced therapy manufacturing footprint in the world. Through our partnerships with the leaders in cell and gene therapy, we have pioneered best practices that speed product to market.
10
Cell, gene and novel therapies industrialized
20
Cell therapy trials started in the last 5 years
50
R&D projects supported in the last 2 years
6
in tech ops capital investments managed
A transformational approach to delivering cell and gene therapies
Few solution providers for cell and gene therapies can offer the pioneering expertise of Precision. Fewer still have integrated the specialized capabilities that can help compress timelines and find efficiencies throughout a development process that will almost certainly encounter scientific and logistical complexities.
-
Explore
Clinical Trial Development
From pre-clinical through registration studies, our experts are leaders in the advancement of cell and gene therapy development, leveraging the research interests of the sites to build clinical enthusiasm, supporting the logistical complexities of these trials, and addressing complex safety issues.
-
Explore
Specialty Lab Services
Cell and gene therapy research requires specialized expertise to support successful translation from the bench to the clinic. We deliver, with a broad array of both established and Precision-engineered platforms targeted specifically to the needs of cell or gene therapy development, and thought leaders who are helping shape the therapeutic and regulatory landscape.
-
Explore
Manufacturing Solutions
You’ll start with the team that led the industrialization of the most notable FDA-approved advanced therapies—and built the world’s largest cell and gene therapy manufacturing footprint. We help cell and gene therapy trials achieve operational excellence, accelerating speed to market for life-changing therapies.
-
Explore
Companion Diagnostics
The success of your cell or gene therapy ultimately relies on accurate identification of appropriate candidates for treatment. These treatments often require a Companion Diagnostic (CDx). Precision has the required specialized clinical development, biomarker assay, regulatory strategy and commercialization capabilities.
Industry insights from cell and gene therapy experts
US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma?
